Ultraschall Med 2013; 34(1): 11-29
DOI: 10.1055/s-0032-1325499
© Georg Thieme Verlag KG Stuttgart · New York

Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012

A WFUMB-EFSUMB Initiative in Cooperation With Representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS
M. Claudon
1   Department of Pediatric Radiology, INSERM U947, Centre Hospitalier Universitaire de Nancy and Université de Lorraine, Vandoeuvre, France
C. F. Dietrich
2   Medizinische Klinik 2, Caritas-Krankenhaus Bad Mergentheim, Germany
B. I. Choi
3   Department of Radiology, Seoul National University Hospital, Seoul, Korea
D. O. Cosgrove
4   Imaging Sciences Department, Imperial College, Hammersmith Hospital, London, United Kingdom
M. Kudo
5   Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan
C. P. Nolsøe
6   Ultrasound Section, Division of Surgery, Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
F. Piscaglia
7   Division of Internal Medicine, University of Bologna, Bologna, Italy
S. R. Wilson
8   Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada
R. G. Barr
9   Northeastern Ohio Medical University, Rootstown, Ohio, United States of America
M. C. Chammas
10   Institute of Radiology, School of Medicine, University of São Paulo, São Paulo, Brazil
N. G. Chaubal
11   Thane Ultrasound Centre, Jaslok Hospital, Mumbai, India
M.-H. Chen
12   Peking University Cancer Hospital, Peking, China
D. A. Clevert
13   Interdisciplinary Ultrasound Center, Department of Clinical Radiology, University of Munich-Grosshadern Campus, Munich, Germany
J. M. Correas
14   Service de Radiologie Adultes, Hôpital Necker, Université Paris Descartes, Paris, France
H. Ding
15   Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China
F. Forsberg
16   Department of Radiology, Thomas Jefferson University, Philadelphia, Philadelphia, United States of America
J. B. Fowlkes
17   Department of Radiology, University of Michigan, Ann Arbor, Michigan, United States of America
R. N. Gibson
18   Department of Radiology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia
B. B. Goldberg
19   Division of Diagnostic Ultrasound, Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States of America
N. Lassau
20   Integrated Research Cancer Institute in Villejuif, Gustave Roussy Institute, Villejuif, France
E. L. S. Leen
21   Imaging Department, Imperial College, London, United Kingdom
R. F. Mattrey
22   MRI Institute, University of California San Diego, San Diego, California, United States of America
F. Moriyasu
23   Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan
L. Solbiati
24   Department of Interventional Oncologic Radiology, General Hospital of Busto Arsizio, Busto Arsizio, Italy
H.-P. Weskott
25   Central Ultrasound Department, Klinikum Siloah, Klinikum Region Hannover, Hannover, Germany
H.-X. Xu
26   Department of Medical Ultrasound, Tenth People’s Hospital of Tongji University, Shanghai, China
› Author Affiliations
Further Information

Publication History

Publication Date:
05 November 2012 (online)


Initially, a set of guidelines for the use of ultrasound contrast agents was published in 2004 dealing only with liver applications. A second edition of the guidelines in 2008 reflected changes in the available contrast agents and updated the guidelines for the liver, as well as implementing some non-liver applications. Time has moved on, and the need for international guidelines on the use of CEUS in the liver has become apparent. The present document describes the third iteration of recommendations for the hepatic use of contrast enhanced ultrasound (CEUS) using contrast specific imaging techniques. This joint WFUMB-EFSUMB initiative has implicated experts from major leading ultrasound societies worldwide. These liver CEUS guidelines are simultaneously published in the official journals of both organizing federations (i.e., Ultrasound in Medicine and Biology for WFUMB and Ultraschall in der Medizin/European Journal of Ultrasound for EFSUMB). These guidelines and recommendations provide general advice on the use of all currently clinically available ultrasound contrast agents (UCA). They are intended to create standard protocols for the use and administration of UCA in liver applications on an international basis and improve the management of patients worldwide.

  • References

  • 19 Deutsche Krebsgesellschaft e. V. (DKG), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) (Hrsg) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. München: Zuckschwerdt; 2008
  • 1 EFSUMB (European Federation of Societies for Ultrasound in Medicine and Biology). Minimum training recommendations for the practice of medical ultrasound. Ultraschall in Med 2006; 27: 79-105
  • 2 International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49: 658-664
  • 3 EFSUMB (European Federation of Societies for Ultrasound in Medicine and Biology). Minimum training requirements for the practice of Medical Ultrasound in Europe. Ultraschall in Med 2010; 31: 426-427
  • 4 Adam R, Bismuth H, Castaing D et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225: 51-60 , discussion 62
  • 5 Albrecht T, Blomley M, Bolondi L et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall in Med 2004; 25: 249-256
  • 6 Arita J, Hasegawa K, Takahashi M et al. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. Am J Roentgenol 2011; 196: 1314-1321
  • 7 Averkiou M, Powers J, Skyba D et al. Ultrasound contrast imaging research. Ultrasound Q 2003; 19: 27-37
  • 8 Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelines. J Hepatol 2012; 57: 930-932
  • 9 Bernatik T, Seitz K, Blank W et al. Unclear focal liver lesions in contrast-enhanced ultrasonography – lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall in Med 2010; 31: 577-581
  • 10 Berstad AE, Brabrand K, Foss A. Clinical utility of microbubble contrast-enhanced ultrasound in the diagnosis of hepatic artery occlusion after liver transplantation. Transpl Int 2009; 22: 954-960
  • 11 Bolondi L, Gaiani S, Celli N et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42: 27-34
  • 12 Boozari B, Soudah B, Rifai K et al. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography – a prospective study. Dig Liver Dis 2011; 43: 484-490
  • 13 Bos LJ, Piek JJ, Spaan JA. Background subtraction from time-intensity curves in videodensitometry: a pitfall in flow assessment using contrast echocardiography. Ultrasound Med Biol 1995; 21: 1211-1218
  • 14 Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236
  • 15 Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022
  • 16 Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
  • 17 Cantisani V, Ricci P, Erturk M et al. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue(R) low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI. Ultraschall in Med 2010; 31: 500-505
  • 18 Cao BS, Li XL, Li N et al. The nodular form of hepatic tuberculosis: contrast-enhanced ultrasonographic findings with pathologic correlation. J Ultrasound Med 2010; 29: 881-888
  • 19 Catalano O, Sandomenico F, Nunziata A et al. Transient hepatic echogenicity difference on contrast-enhanced ultrasonography: sonographic sign and pitfall. J Ultrasound Med 2007; 26: 337-345
  • 20 Catalano O, Sandomenico F, Raso MM et al. Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. Am J Roentgenol 2004; 182: 447-450
  • 21 Cervone A, Sardi A, Conaway GL. Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 2000; 66: 611-615
  • 22 Chami L, Lassau N, Malka D et al. Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. Am J Roentgenol 2008; 190: 683-690
  • 23 Charnley RM, Morris DL, Dennison AR et al. Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg 1991; 78: 45-48
  • 24 Chen LD, Xu HX, Xie XY et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 2008; 81: 881-889
  • 25 Chen LD, Xu HX, Xie XY et al. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 2010; 20: 743-753
  • 26 Chen MH, Dai Y, Yan K et al. The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (≤ 3cm) in patients with cirrhosis. Hepatol Res 2006; a 35: 281-288
  • 27 Chen MH, Wei Y, Yan K et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 2006; b 17: 671-683
  • 28 Chen MH, Yang W, Yan K et al. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol 2007; 62: 752-760
  • 29 Chen MH, Yang W, Yan K et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients – mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232: 260-271
  • 30 Choi D, Lim HK, Lee WJ et al. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 2003; 22: 1163-1172
  • 31 Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall in Med 2008; 29: 28-44
  • 32 Clevert DA, Stickel M, Minaifar N et al. Contrast-enhanced ultrasound in liver transplant: first results and potential for complications in the postoperative period. Clin Hemorheol Microcirc 2009; 43: 83-94
  • 33 Conlon R, Jacobs M, Dasgupta D et al. The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound 2003; 16: 211-216
  • 34 Cosgrove D, Harvey C. Clinical uses of microbubbles in diagnosis and treatment. Med Biol Eng Comput 2009; 47: 813-826
  • 35 Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010; 37 (Suppl. 01) S65-S85
  • 36 Crocetti L, Lencioni R, Debeni S et al. Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system. Invest Radiol 2008; 43: 33-39
  • 37 Dawson P, Cosgrove D, Grainger R. Textbook of contrast media. Oxford: ISIS Medical Media; 1999
  • 38 De Giorgi U, Aliberti C, Benea G et al. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors. Clin Cancer Res 2005; 11: 6171-6176
  • 39 Dietrich CF, Averkioui MA, Correas JM et al. An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall in Med 2012; 33: 344-351
  • 40 Dietrich CF, Braden B, Hocke M et al. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol 2008; 134: 635-643
  • 41 Dietrich CF, Ignee A, Hocke M et al. Pitfalls and artefacts using contrast enhanced ultrasound. Z Gastroenterol 2011; 49: 350-356
  • 42 Dietrich CF, Kratzer W, Strobe D et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-1705
  • 43 Dietrich CF, Mertens JC, Braden B et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007; b 45: 1139-1145
  • 44 Dietrich CF, Schuessler G, Trojan J et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78: 704-707
  • 45 Ding H, Wang WP, Huang BJ et al. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue. J Ultrasound Med 2005; 24: 285-297
  • 46 Dodd 3rd GD, Memel DS, Zajko AB et al. Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time. Radiology 1994; 192: 657-661
  • 47 Ellsmere J, Kane R, Grinbaum R et al. Intraoperative ultrasonography during planned liver resections: why are we still performing it?. Surg Endosc 2007; 21: 1280-1283
  • 48 Exuzides A, Main ML, Colby C et al. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. JACC Cardiovasc Imaging 2010; 3: 578-585
  • 49 Fan ZH, Chen MH, Dai Y et al. Evaluation of primary malignancies of the liver using contrast- enhanced sonography: correlation with pathology. Am J Roentgenol 2006; 186: 1512-1519
  • 50 Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438: 967-974
  • 51 Finlay IG, Meek D, Brunton F et al. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg 1988; 75: 641-644
  • 52 Fioole B, de Haas RJ, Wicherts DA et al. Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol 2008; 67: 169-176
  • 53 Flint EW, Sumkin JH, Zajko AB et al. Duplex sonography of hepatic artery thrombosis after liver transplantation. Am J Roentgenol 1988; 151: 481-483
  • 54 Fong Y. Hepatic colorectal metastasis: current surgical therapy, selection criteria for hepatectomy, and role for adjuvant therapy. Adv Surg 2000; 34: 351-381
  • 55 Forner A, Vilana R, Ayuso C et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47: 97-104
  • 56 Forsberg F, Kuruvilla B, Pascua MB et al. Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity. Ultrasound Med Biol 2008; 34: 1365-1372
  • 57 Foschi FG, Dall’Aglio AC, Marano G et al. Role of contrast-enhanced ultrasonography in primary hepatic lymphoma. J Ultrasound Med 2010; 29: 1353-1356
  • 58 Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213
  • 59 Guibal A, Taillade L, Mule S et al. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. Radiology 2010; 254: 420-429
  • 60 Hatanaka K, Kudo M, Minami Y et al. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; a 75 (Suppl. 01) 42-47
  • 61 Hatanaka K, Kudo M, Minami Y et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent. Sonazoid. Intervirology 2008; b 51 (Suppl. 01) 61-69
  • 62 Hirche TO, Ignee A, Hirche H et al. Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection. Liver Int 2007; 27: 748-757
  • 63 Huang D, Chen Y, Li K et al. Hemodynamic changes on color Doppler flow imaging and intravenous contrast-enhanced ultrasound for assessing transplanted liver and early diagnosis of complications. J Huazhong Univ Sci Technolog Med Sci 2008; 28: 284-286
  • 64 Iavarone M, Sangiovanni A, Forzenigo LV et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology 2010; 52: 1723-1730
  • 65 Ignee A, Piscaglia F, Ott M et al. A benign tumour of the liver mimicking malignant liver disease – cholangiocellular adenoma. Scand J Gastroenterol 2009; 44: 633-636
  • 66 Inoue T, Kudo M, Hatanaka K et al. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images. Oncology 2008; 75 (Suppl. 01) 48-54
  • 67 Jain A, Reyes J, Kashyap R et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000; 232: 490-500
  • 68 Jang HJ, Kim TK, Burns PN et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244: 898-906
  • 69 Jarnagin WR, Bach AM, Winston CB et al. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease?. J Am Coll Surg 2001; 192: 577-583
  • 70 Kessler T, Bayer M, Schwoppe C et al. Compounds in clinical Phase III and beyond. Recent Results Cancer Res 2010; 180: 137-163
  • 71 Khawaja OA, Shaikh KA, Al-Mallah MH. Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents. Am J Cardiol 2010; 106: 742-747
  • 72 Kisaka Y, Hirooka M, Kumagi T et al. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 2006; 26: 1241-1247
  • 73 Konopke R, Bunk A, Kersting S. Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy. Ultraschall in Med 2008; 29 (Suppl. 04) S203-S209
  • 74 Konopke R, Kersting S, Bergert H et al. Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007; 22: 201-207
  • 75 Korenaga K, Korenaga M, Furukawa M et al. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2009; 44: 733-741
  • 76 Kudo M. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol 2010; 25: 439-452
  • 77 Kudo M, Hatanaka K, Kumada T et al. Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma. Am J Gastroenterol 2011; a 106: 368-370
  • 78 Kudo M, Hatanaka K, Maekawa K. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma. Oncology 2010; 78 (Suppl. 01) 40-45
  • 79 Kudo M, Izumi N, Kokudo N et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; b 29: 339-364
  • 80 Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72 (Suppl. 01) 2-15
  • 81 Kurt M, Shaikh KA, Peterson L et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol 2009; 53: 802-810
  • 82 Lamuraglia M, Escudier B, Chami L et al. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound. Eur J Cancer 2006; 42: 2472-2479
  • 83 Langnas AN, Marujo W, Stratta RJ et al. Vascular complications after orthotopic liver transplantation. Am J Surg 1991; 161: 76-82 ; discussion 83
  • 84 Larsen LP, Rosenkilde M, Christensen H et al. The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol 2007; 62: 302-307
  • 85 Lassau N, Chami L, Chebil M et al. Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. Discov Med 2011; 11: 18-24
  • 86 Lassau N, Chami L, Koscielny S et al. Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE- US) in GIST patients treated with masatinib. Invest New Drugs 2012; 30: 765-771
  • 87 Lassau N, Koscielny S, Albiges L et al. Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography. Clin Cancer Res 2010; a 16: 1216-1225
  • 88 Lassau N, Koscielny S, Chami L et al. Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification–Preliminary Results. Radiology 2010; b 258: 291-300
  • 89 Lassau N, Lamuraglia M, Chami L et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. Am J Roentgenol 2006; 187: 1267-1273
  • 90 Leen E, Ceccotti P, Moug SJ et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?. Ann Surg 2006; 243: 236-240
  • 91 Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60
  • 92 Leoni S, Piscaglia F, Golfieri R et al. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 2010; 105: 599-609
  • 93 Li N, Ding H, Fan P et al. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. Ultrasound Med Biol 2010; 36: 1066-1075
  • 94 Lim AK, Taylor-Robinson SD, Patel N et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005; 54: 128-133
  • 95 Liu GJ, Lu MD, Xie XY et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions. J Ultrasound Med 2008; a 27: 657-666
  • 96 Liu JB, Wansaicheong G, Merton DA et al. Canine prostate: contrast-enhanced US-guided radiofrequency ablation with urethral and neurovascular cooling–initial experience. Radiology 2008; b 247: 717-725
  • 97 Liu Z, Lobo SM, Humphries S et al. Radiofrequency tumor ablation: insight into improved efficacy using computer modeling. Am J Roentgenol 2005; 184: 1347-1352
  • 98 Livraghi T, Goldberg SN, Lazzaroni S et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214: 761-768
  • 99 Lu Q, Zhong XF, Huang ZX et al. Role of contrast-enhanced ultrasound in decision support for diagnosis and treatment of hepatic artery thrombosis after liver transplantation. Eur J Radiol 2012; 81: e338-e343
  • 100 Luo Y, Fan YT, Lu Q et al. CEUS: a new imaging approach for postoperative vascular complications after right-lobe LDLT. World J Gastroenterol 2009; 15: 3670-3675
  • 101 Main ML, Goldman JH, Grayburn PA. Ultrasound contrast agents: balancing safety versus efficacy. Expert Opin Drug Saf 2009; 8: 49-56
  • 102 Main ML, Ryan AC, Davis TE et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 2008; 102: 1742-1746
  • 103 Mandry D, Bressenot A, Galloy MA et al. Contrast-enhanced ultrasound in fibro-lamellar hepatocellular carcinoma: a case report. Ultraschall in Med 2007; 28: 547-552
  • 104 Maruyama H, Takahashi M, Ishibashi H et al. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int 2009; 29: 708-714
  • 105 Matsui O. Detection and characterization of hepatocellular carcinoma by imaging. Clin Gastroenterol Hepatol 2005; 3: S136-S140
  • 106 Mazzoni G, Napoli A, Mandetta S et al. Intra-operative ultrasound for detection of liver metastases from colorectal cancer. Liver Int 2008; 28: 88-94
  • 107 Minami Y, Kudo M, Chung H et al. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. Am J Roentgenol 2007; 188: 489-494
  • 108 Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. Am J Roentgenol 2009; 193: 86-95
  • 109 Mork H, Ignee A, Schuessler G et al. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol 2007; 42: 652-662
  • 110 Nakano H, Ishida Y, Hatakeyama T et al. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. World J Gastroenterol 2008; 14: 3207-3211
  • 111 Omata M, Lesmana LA, Tateishi R et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474
  • 112 Peronneau P, Lassau N, Leguerney I et al. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization. Ultraschall in Med 2010; 31: 370-378
  • 113 Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32: 1369-1375
  • 114 Piscaglia F, Corradi F, Mancini M et al. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer 2007; 7: 171
  • 115 Piscaglia F, Gianstefani A, Ravaioli M et al. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl 2010; 16: 658-667
  • 116 Piscaglia F, Nolsoe C, Dietrich CF et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall in Med 2011; 33: 33-59
  • 117 Piskunowicz M, Kosiak W, Irga N. Primum non nocere? Why can’t we use second generation ultrasound contrast agents for the examination of children?. Ultraschall in Med 2011; 32: 83-86
  • 118 Qiang L, Yan L, Chao-Xin Y et al. Value of contrast enhanced intraoperative ultrasound for cirrhotic patients with hepatocellular carcinoma. A report of 20 cases. World J Gastroenterol 2008; 14: 4005-4010
  • 119 Quaia E, D’Onofrio M, Palumbo A et al. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-1609
  • 120 Ridolfi F, Abbattista T, Marini F et al. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liver Dis 2007; 39: 929-935
  • 121 Rossi S, Rosa L, Ravetta V et al. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. Am J Roentgenol 2006; 186: 763-773
  • 122 Sangiovanni A, Manini MA, Iavarone M et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010; 59: 638-644
  • 123 Sasaki A, Kai S, Iwashita Y et al. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005; 103: 299-306
  • 124 Scheele J, Stang R, Altendorf-Hofmann A et al. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71
  • 125 Schlottmann K, Klebl F, Zorger N et al. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. Z Gastroenterol 2004; 42: 303-310
  • 126 Schuessler G, Fellbaum C, Fauth F et al. The infammatory pseudotumour – an unusual liver tumour. Ultraschall in Med 2006; 27: 273-279
  • 127 Seitz K, Bernatik T, Strobel D et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI – a prospective comparison in 269 patients. Ultraschall in Med 2010; 31: 492-499
  • 128 Seitz K, Greis C, Schuler A et al. Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study. Ultraschall in Med 2011; 32: 598-603
  • 129 Shaw AS, Ryan SM, Beese RC et al. Ultrasound of non-vascular complications in the post liver transplant patient. Clin Radiol 2003; 58: 672-680
  • 130 Shiozawa K, Watanabe M, Takayama R et al. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. J Clin Ultrasound 2010; 38: 182-189
  • 131 Sidhu PS, Shaw AS, Ellis SM et al. Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography. Eur Radiol 2004; 14: 21-30
  • 132 Simpson DH, Chin CT, Burns PN. Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans on Ultrasonics, Ferroelectrics, and Freq Control 1999; 46: 372-382
  • 133 Skyba DM, Price RJ, Linka AZ et al. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998; 98: 290-293
  • 134 Sorrentino P, D’Angelo S, Tarantino L et al. Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World J Gastroenterol 2009; 15: 2245-2251
  • 135 Strobel D, Kleinecke C, Hansler J et al. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas–correlation with histological differentiation. Ultraschall in Med 2005; 26: 270-276
  • 136 Strobel D, Seitz K, Blank W et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions–diagnostic accuracy in clinical practice (DEGUM multicenter trial). Ultraschall in Med 2008; 29: 499-505
  • 137 Su HL, Qian YQ, Wei ZR et al. Real-time myocardial contrast echocardiography in rat: infusion versus bolus administration. Ultrasound Med Biol 2009; 35: 748-755
  • 138 Szabo T. Diagnostic Ultrasound Imaging. Insite Out (Biomedical Engineering); ISBN 0125801452. Ed./Academic Press 2004
  • 139 Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216
  • 140 Tiemann K, Lohmeier S, Kuntz S et al. Real-time contrast echo assessment of myocardial perfusion at low emission power: First experimental and clinical results using power pulse inversion imaging. Echocardiography 1999; 16: 799-809
  • 141 Torzilli G, Del Fabbro D, Palmisano A et al. Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg 2005; 9: 1148-1153 ; discussion 53-54
  • 142 Torzilli G, Del Fabbro D, Palmisano A et al. Contrast-enhanced intraoperative ultrasonography: a valuable and not any more monocentric diagnostic technique performed in different ways. Ann Surg 2007; 245: 152-153 ; author reply 153.
  • 143 Trillaud H, Bruel JM, Valette PJ et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol 2009; 15: 3748-3756
  • 144 Vilana R, Forner A, Bianchi L et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 2010; 51: 2020-2029
  • 145 Wang Z, Xu HX, Xie XY et al. Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound. Br J Radiol 2010; 83: 411-418
  • 146 Wei K, Jayaweera AR, Firoozan S et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97: 473-483
  • 147 Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. Am J Roentgenol 2006; 186: 1401-1412
  • 148 Wilson SR, Kim TK, Jang HJ et al. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. Am J Roentgenol 2007; 189: W7-W12
  • 149 World Health Organisation Offset Publication. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: ISBN 92 4 170048 3. Ed World Health Organisation, 1979.
  • 150 Wu W, Chen MH, Yin SS et al. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. Am J Roentgenol 2006; 187: 752-761
  • 151 Xu HX, Liu GJ, Lu MD et al. Characterization of small focal liver lesions using real-time contrast- enhanced sonography: diagnostic performance analysis in 200 patients. J Ultrasound Med 2006; a 25: 349-361
  • 152 Xu HX, Lu MD, Liu GJ et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006; b 25: 23-33
  • 153 Yanagisawa K, Moriyasu F, Miyahara T et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007; 33: 318-325
  • 154 Zheng RQ, Mao R, Ren J et al. Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: potential role in changing the clinical algorithm. Liver Transpl 2010; 16: 729-735